SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-24-001442
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:34
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240331x6k.htm 6-K 15605
2 EX-99.1 tmb-20240331xex99d1.htm   iXBRL EX-99.1 1300362
3 EX-99.2 tmb-20240331xex99d2.htm EX-99.2 550888
  Complete submission text file 0001410578-24-001442.txt   7505395

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20240331.xsd EX-101.SCH 57241
5 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 69493
6 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 126244
7 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 452312
8 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 312346
79 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331xex99d1_htm.xml XML 1384935
Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-0937-2689523
Qilian International Holding Group Ltd (Filer) CIK: 0001779578 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-39805 | Film No.: 241208053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)